Skip to content

What is the use of glycophos?: Understanding its Role in Intravenous Nutrition

4 min read

Over 2% of hospitalized patients experience hypophosphatemia, creating a critical need for phosphorus supplementation. So, what is the use of glycophos? It is a sterile intravenous solution of sodium glycerophosphate used primarily to meet phosphate requirements during parenteral (intravenous) nutrition.

Quick Summary

Glycophos is a sterile, intravenous organic phosphate supplement (sodium glycerophosphate) primarily used to treat or prevent low phosphate levels during parenteral nutrition, particularly for patients unable to receive oral phosphate.

Key Points

  • Intravenous Phosphate Supplement: Glycophos, or sodium glycerophosphate, is an organic phosphate salt administered intravenously.

  • Treats Hypophosphatemia: Its primary use is to treat or prevent low phosphate levels in the blood, a condition known as hypophosphatemia.

  • Used in Parenteral Nutrition: It serves as a crucial phosphate source for patients receiving total parenteral nutrition (intravenous feeding).

  • Unique Chemical Profile: As an organic phosphate, it is more compatible with calcium in IV solutions than inorganic phosphates, reducing precipitation risk.

  • Provides Sodium, Not Potassium: Glycophos is a sodium-based supplement, making it a suitable option for patients who require phosphate but should avoid additional potassium.

  • Requires Dilution: Glycophos is a concentrate that must be diluted before being infused into a patient.

  • Dosage is Individualized: The correct dose depends on the patient's individual phosphate needs.

In This Article

What is Glycophos?

Glycophos is the brand name for sodium glycerophosphate, a soluble organic phosphate salt administered intravenously. Unlike other phosphate supplements that contain inorganic phosphate, Glycophos provides an organic form that is gradually hydrolyzed in the body to release inorganic phosphate and glycerol. This characteristic is particularly important in the context of intravenous nutrient solutions, where it provides a more compatible and stable source of phosphate.

Treating and Preventing Hypophosphatemia

One of the primary uses of Glycophos is to correct or prevent hypophosphatemia, a condition characterized by abnormally low phosphate levels in the blood. Phosphate is a vital mineral essential for numerous bodily functions, including:

  • Cellular energy production: It is a key component of adenosine triphosphate (ATP), the body's main energy currency.
  • Structural components: Phosphate is an integral part of DNA, RNA, and phospholipids, which are crucial for cell membrane integrity.
  • Bone health: It plays a major role in the mineralization and maintenance of bone tissue.
  • Muscle and nerve function: Proper phosphate levels are necessary for normal muscle contraction and nerve signal transmission.

Patients can develop hypophosphatemia due to various causes, such as refeeding syndrome, malnutrition, burns, and other critical illnesses. For those who cannot receive phosphate orally, intravenous administration of Glycophos is a critical treatment.

Use in Parenteral Nutrition

Parenteral nutrition, or intravenous feeding, is a method of delivering nutrients directly into the bloodstream for patients who cannot eat or absorb food through the gastrointestinal tract. Glycophos is frequently used as a supplement in these nutritional solutions for both adults and infants to fulfill their daily phosphate requirements. During parenteral nutrition, it provides a consistent and controlled source of phosphate that is essential for metabolic processes.

Mechanism of Action

Upon administration, the sodium glycerophosphate in Glycophos is hydrolyzed by alkaline phosphatases in the body. This process breaks down the organic compound, releasing the inorganic phosphate that the body needs. This mechanism ensures a gradual and controlled delivery of phosphate, which helps to avoid rapid, potentially dangerous fluctuations in blood levels.

The Importance of Compatibility

Organic phosphate, as found in Glycophos, is known to have better compatibility with calcium in parenteral nutrition admixtures compared to inorganic phosphate sources. This means that calcium and phosphate can exist together in higher concentrations without precipitating out of the solution, which is a significant safety advantage in intravenous preparations.

Comparison of Phosphate Supplements

The choice of phosphate supplement depends on the patient's overall electrolyte status. The primary alternative to Glycophos involves inorganic phosphate salts, which differ in their mineral composition and properties.

Feature Glycophos (Sodium Glycerophosphate) Potassium Phosphate / Sodium Phosphate
Phosphate Type Organic Inorganic
Composition Sodium and phosphate Potassium, sodium, and phosphate
Calcium Compatibility High; allows higher concentrations without precipitation Lower; increased risk of precipitation at higher concentrations
Key Consideration Used when additional sodium is needed along with phosphate, and potassium is not desired. Used when potassium is also required or needs to be replaced.

Administration and Dosage

Glycophos is a concentrated solution intended for intravenous infusion only after it has been properly diluted. It must never be administered undiluted. The appropriate dosage is determined by a healthcare professional based on the individual patient's clinical needs, including their phosphate status and overall nutritional requirements. Regular monitoring of serum phosphate and other electrolytes is crucial during treatment.

Potential Side Effects and Precautions

Like all medications, Glycophos carries potential side effects, and certain precautions must be taken.

Side Effects

  • Electrolyte Imbalances: The most significant risks are hyperphosphatemia (high phosphate levels) and hypernatremia (high sodium levels) due to over-supplementation. This can lead to hypocalcemia (low calcium) as phosphate can bind to calcium in the bloodstream.
  • Gastrointestinal: Mild and temporary nausea, vomiting, or stomach upset may occur.
  • Fluid and Electrolyte Problems: More severe issues, such as mood changes, confusion, muscle weakness, and seizures, can occur with significant electrolyte imbalances.

Precautions

Glycophos should not be used in patients with:

  • Dehydration
  • Existing hypernatremia or hyperphosphatemia
  • Severe renal insufficiency
  • Shock

Healthcare providers must regularly monitor phosphate and other electrolyte levels in all patients receiving Glycophos, especially those with impaired renal function. It is also essential to inform the doctor of all other medications, as interactions are possible. More detailed prescribing information is available from the manufacturer. Fresenius Kabi, for example, provides information on their website, as referenced in FDA resources.

Conclusion

In summary, the use of glycophos is primarily to provide a safe and compatible source of organic phosphate for intravenous administration. Its main application is for patients receiving parenteral nutrition and to correct hypophosphatemia, especially when oral intake is not feasible. Its key benefit lies in its compatibility with calcium in nutritional solutions, which is a crucial consideration in complex IV admixtures. As a prescription medication, its use is carefully managed by healthcare professionals to monitor electrolyte levels and prevent adverse effects, ensuring that patients receive the essential phosphate needed for critical metabolic functions.

Frequently Asked Questions

The active ingredient in Glycophos is sodium glycerophosphate, which is a soluble organic phosphate salt.

Glycophos is administered as an intravenous infusion. It is a concentrate that must be diluted in a suitable infusion solution before it is given to the patient.

Hypophosphatemia is a medical condition characterized by abnormally low levels of phosphate in the blood. It can cause various symptoms, including muscle weakness, confusion, and fatigue.

Common side effects may include mild gastrointestinal discomfort. More serious, though less frequent, side effects can arise from electrolyte imbalances, such as hyperphosphatemia or hypernatremia.

Glycophos is contraindicated in patients who are dehydrated, or who have hypernatremia (high sodium), hyperphosphatemia (high phosphate), severe renal insufficiency, or are in shock.

Glycophos contains an organic phosphate, which makes it more compatible with calcium in intravenous solutions compared to inorganic phosphate supplements.

Glycophos provides phosphate and sodium, whereas potassium phosphate provides phosphate and potassium. Glycophos is used for patients who need phosphate and require additional sodium, but should not have additional potassium.

Parenteral nutrition is a method of feeding patients intravenously when they are unable to take food orally or absorb nutrients through their digestive system.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.